Nanocarrier Co. Ltd. (TYO:4571) plans to apply in fiscal 2018 to conduct Phase I clinical trials in the U.S. using…...
Please subscribe to read the full story.
Japan's leading chemical industry newspaper
Footer
© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.
